about
Congenital thrombotic thrombocytopenic purpura (cTTP) with two novel mutations.Hereditary ADAMTS 13 deficiency presenting as recurrent acute kidney injury.Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab.ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.BM ageing: Implication for cell therapy with EPCs.Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall.A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO)Precise Therapy for Thoracic Aortic Aneurysm in Marfan Syndrome: A Puzzle Nearing Its SolutionSoluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patientsCyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling.New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical EvidenceCardiac fibrosis in regenerative medicine: destroy to rebuildCyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome PatientsSensitive and quantitative method to evaluate DNA methylation of the positive regulatory domains (PRDI, PRDII) and cAMP response element (CRE) in human endothelial nitric oxide synthase promoterImpact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes
P50
Q33400649-30737819-4CE4-4B58-A38D-AFB2CC516ADEQ33404440-278FBC7E-482D-47B2-8DA8-659F33644738Q33406025-C726E5F9-D873-432F-8685-33B815568E71Q33425651-95E5D9FF-DAD0-4472-BA06-94CCFBA6D344Q33426242-FA2157E3-B559-4189-9619-E0C4C41ABB4FQ37193285-8C63913B-AE50-498F-9C08-733EF0916026Q38798433-72B384C0-F8B8-4B5D-A7C6-9569DC632606Q38930482-11E2FF42-0F30-4730-BEEE-BF94774EFB8BQ52804042-E53C6C8B-7B84-442A-8653-393F12292AE0Q58741622-0D809890-AC1E-4F3D-8755-5F893D57F13FQ64044141-29D54862-4955-4FA4-8AA1-52D6B377BB48Q64277451-7FB35C97-C06B-4073-94B1-B89DD6FBC9A1Q64992918-6BA683D7-7B98-49C5-A137-3682AC159491Q89874189-25D16514-56BD-4113-8E89-7AF9F0A157EFQ91030934-2660B332-BC13-4276-9DBB-B70CB5696E3DQ92634017-ED0440C3-A1EA-4755-872E-D6B03BFC4A9CQ92671949-B40B8CB6-B0B5-41CF-98E2-A5885662BAA3Q92712672-60102D9C-0CDF-4824-BB53-40E05AE01613
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Erica Rurali
@ast
Erica Rurali
@en
Erica Rurali
@es
Erica Rurali
@nl
Erica Rurali
@sl
type
label
Erica Rurali
@ast
Erica Rurali
@en
Erica Rurali
@es
Erica Rurali
@nl
Erica Rurali
@sl
prefLabel
Erica Rurali
@ast
Erica Rurali
@en
Erica Rurali
@es
Erica Rurali
@nl
Erica Rurali
@sl
P108
P106
P1153
55386136700
P21
P31
P496
0000-0002-7291-5811